This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurin, M.
Right arrow Articles by Raoult, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurin, M.
Right arrow Articles by Raoult, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2002, p. 3065-3067, Vol. 46, No. 9
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.9.3065-3067.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Antibiotic Susceptibilities of Parachlamydia acanthamoeba in Amoebae

M. Maurin,1 A. Bryskier,2 and D. Raoult1*

Unité des Rickettsies, CNRS UPRES A 6020, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05,1 Anti-Infective Research Department, Hoechst-Marion-Roussel, 93235 Romainville, France2

Received 6 August 2001/ Returned for modification 8 April 2002/ Accepted 5 June 2002

Parachlamydia acanthamoeba are intracellular bacteria of amoebae and are considered potential etiological agents of human pneumonia. We have determined the in vitro antibiotic susceptibilities of two strains (strain Bn9 and Hall's coccus) in Acanthamoeba polyphaga. The two strains were susceptible to tetracyclines, macrolides, and rifampin, but resistant to fluoroquinolones.

* Corresponding author. Mailing address: Unité des Rickettsies, CNRS UMR 6020, IFR 48, Faculté de Médecine, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France. Phone: (33) 4 91 38 55 17. Fax: (33) 4 91 83 03 90. E-mail: Didier.Raoult{at}medecine.univ-mrs.fr.

Antimicrobial Agents and Chemotherapy, September 2002, p. 3065-3067, Vol. 46, No. 9
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.9.3065-3067.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Goy, G., Greub, G. (2009). Antibiotic Susceptibility of Waddlia chondrophila in Acanthamoeba castellanii Amoebae. Antimicrob. Agents Chemother. 53: 2663-2666 [Abstract] [Full Text]  
  • Matsuo, J., Hayashi, Y., Nakamura, S., Sato, M., Mizutani, Y., Asaka, M., Yamaguchi, H. (2008). Novel Parachlamydia acanthamoebae Quantification Method Based on Coculture with Amoebae. Appl. Environ. Microbiol. 74: 6397-6404 [Abstract] [Full Text]  
  • Corsaro, D., Greub, G. (2006). Pathogenic Potential of Novel Chlamydiae and Diagnostic Approaches to Infections Due to These Obligate Intracellular Bacteria. Clin. Microbiol. Rev. 19: 283-297 [Abstract] [Full Text]  
  • Roig, J., Rello, J. (2003). Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 51: 1119-1129 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»